Lifevantage (NASDAQ:LFVN) Given New $8.00 Price Target at Freedom Broker

Lifevantage (NASDAQ:LFVN) had its target price lowered by Freedom Broker from $9.00 to $8.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.

LFVN has been the subject of a number of other reports. Lake Street Capital increased their price target on Lifevantage from $5.00 to $6.00 and gave the company a “hold” rating in a research note on Friday, August 28th. Weiss Ratings restated a “hold (c)” rating on shares of Lifevantage in a research report on Friday, August 21st. Finally, Zacks Research cut Lifevantage from a “hold” rating to a “strong sell” rating in a report on Friday, October 16th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $6.75.

Lifevantage Stock Performance

Shares of Lifevantage stock traded down $0.07 during midday trading on Friday, hitting $4.97. 111,492 shares of the company traded hands, compared to its average volume of 33,719. The stock has a market cap of $63.02 million, a price-to-earnings ratio of 23.67 and a beta of 0.71. The firm’s fifty day moving average price is $5.93 and its 200-day moving average price is $5.86. Lifevantage has a 12 month low of $3.90 and a 12 month high of $11.71.

Lifevantage (NASDAQ:LFVN) last issued its quarterly earnings data on Monday, November 9th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.01). Lifevantage had a net margin of 1.58% and a return on equity of 16.35%. The company had revenue of $37.12 million during the quarter, compared to the consensus estimate of $40.49 million. Equities research analysts forecast that Lifevantage will post 0.39 earnings per share for the current year.

Lifevantage Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 1st will be issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 4.0%. The ex-dividend date of this dividend is Tuesday, December 1st. Lifevantage’s payout ratio is presently 95.24%.

Insiders Place Their Bets

In other Lifevantage news, insider Kristen Cunningham sold 8,901 shares of the company’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $6.18, for a total value of $55,008.18. Following the completion of the transaction, the insider directly owned 120,162 shares in the company, valued at approximately $742,601.16. This represents a 6.90% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 13.58% of the stock is owned by insiders.

Hedge Funds Weigh In On Lifevantage

Hedge funds have recently modified their holdings of the business. Bank of New York Mellon Corp boosted its position in shares of Lifevantage by 11.9% during the 1st quarter. Bank of New York Mellon Corp now owns 33,547 shares of the company’s stock valued at $145,000 after purchasing an additional 3,571 shares in the last quarter. Bank of America Corp DE grew its stake in Lifevantage by 24.3% during the first quarter. Bank of America Corp DE now owns 23,445 shares of the company’s stock worth $101,000 after purchasing an additional 4,586 shares during the period. Hsbc Holdings PLC bought a new stake in Lifevantage in the first quarter worth approximately $51,000. Finally, Engineers Gate Manager LP increased its holdings in Lifevantage by 109.7% in the second quarter. Engineers Gate Manager LP now owns 27,009 shares of the company’s stock worth $169,000 after purchasing an additional 14,131 shares in the last quarter. Institutional investors and hedge funds own 35.32% of the company’s stock.

Lifevantage Company Profile

LifeVantage Corporation is a health and wellness company that develops and sells dietary supplements, skincare products and other wellness offerings. Its product range includes Protandim supplements and the TrueScience skincare line, with products marketed around the company’s focus on nutrigenomics—the study of how nutrition interacts with gene expression. Founded in 2003, LifeVantage primarily sells through independent consultants and online channels. The company serves customers in markets across North America, Europe and the Asia-Pacific region.